1. Home
  2. TELA vs DOMH Comparison

TELA vs DOMH Comparison

Compare TELA & DOMH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TELA
  • DOMH
  • Stock Information
  • Founded
  • TELA 2012
  • DOMH 1967
  • Country
  • TELA United States
  • DOMH United States
  • Employees
  • TELA N/A
  • DOMH N/A
  • Industry
  • TELA Medical/Dental Instruments
  • DOMH Biotechnology: Pharmaceutical Preparations
  • Sector
  • TELA Health Care
  • DOMH Health Care
  • Exchange
  • TELA Nasdaq
  • DOMH Nasdaq
  • Market Cap
  • TELA 73.2M
  • DOMH 74.7M
  • IPO Year
  • TELA 2019
  • DOMH N/A
  • Fundamental
  • Price
  • TELA $1.58
  • DOMH $6.40
  • Analyst Decision
  • TELA Strong Buy
  • DOMH
  • Analyst Count
  • TELA 4
  • DOMH 0
  • Target Price
  • TELA $6.00
  • DOMH N/A
  • AVG Volume (30 Days)
  • TELA 82.9K
  • DOMH 358.3K
  • Earning Date
  • TELA 08-11-2025
  • DOMH 08-11-2025
  • Dividend Yield
  • TELA N/A
  • DOMH 5.00%
  • EPS Growth
  • TELA N/A
  • DOMH N/A
  • EPS
  • TELA N/A
  • DOMH N/A
  • Revenue
  • TELA $75,323,000.00
  • DOMH $52,811,000.00
  • Revenue This Year
  • TELA $26.67
  • DOMH N/A
  • Revenue Next Year
  • TELA $22.63
  • DOMH N/A
  • P/E Ratio
  • TELA N/A
  • DOMH N/A
  • Revenue Growth
  • TELA 16.34
  • DOMH 455.38
  • 52 Week Low
  • TELA $0.86
  • DOMH $0.83
  • 52 Week High
  • TELA $3.26
  • DOMH $13.58
  • Technical
  • Relative Strength Index (RSI)
  • TELA 41.66
  • DOMH 61.78
  • Support Level
  • TELA $1.40
  • DOMH $5.32
  • Resistance Level
  • TELA $2.14
  • DOMH $7.60
  • Average True Range (ATR)
  • TELA 0.23
  • DOMH 0.59
  • MACD
  • TELA -0.04
  • DOMH 0.15
  • Stochastic Oscillator
  • TELA 24.32
  • DOMH 63.53

About TELA TELA Bio Inc.

TELA Bio Inc a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. Its growing product portfolio is purposefully designed to leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. The company's OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair.

About DOMH Dominari Holdings Inc.

Dominari Holdings Inc through its various subsidiaries, is currently engaged in wealth management, investment banking, securities sales and trading and asset management. The company operates in two reportable business segments: Dominari Financial and Legacy AIkido. The Dominari Financial reportable business segment represents the Company's broker-dealer business, which is composed of mostly underwriting and transactional service activities. The Legacy AIkido reportable business segment includes Aikido Labs, which manages the investments holdings of the legacy entity. It generates the majority of its revenue from the Dominari Financial segment.

Share on Social Networks: